Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long‐term outcome and survival
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Summary: Background Primary sclerosing cholangitis/autoimmune hepatitis (PSC/AIH) and primary biliary cirrhosis/AIH (PBC/AIH) overlap syndromes are poorly defined variants of AIH. Few large patient series exist, and there are little data on long‐term outcomes. Aim To compare presentation, clinical course and outcome of patients with PSC/AIH and PBC/AIH, with patients with definite AIH. Methods Two hundred and thirty‐eight AIH patients were compared with 10 PBC/AIH patients and 16 PSC/AIH patients presenting consecutively between 1971 and 2005 at a single centre. Results Autoimmune hepatitis patients were significantly more likely to present with jaundice (69.4% vs. 25%; P = 0.0145) than PBC/AIH patients. Median serum aspartate aminotransferase activity at presentation was higher in AIH patients compared with PBC/AIH and PSC/AIH patients respectively (620 vs. 94 vs. 224 IU/L; P < 0.05). PBC/AIH patients demonstrated no response to standard AIH therapy more frequently than AIH patients (25% vs. 0.8%; P = 0.0057). Significant reduction in survival was identified between patients with PSC/AIH and those without (hazard ratio: PSC/AIH vs. AIH = 2.08, PSC/AIH vs. PBC/AIH = 2.14; P = 0.039). Conclusions Patients with PSC/AIH have severe disease and significantly worse prognosis than patients with AIH or PBC/AIH. Recognition and close follow‐up of this cohort are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationChazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999) · Hepatology · doi:10.1002/hep.510290409 · Cited by 278
Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome
Floreani, A., Rizzotto, E. R., Ferrara, F., Carderi, I., Caroli, D., Blasone, L., & Baldo, V. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41841.x · Cited by 230
Kaya, M., Angulo, P., & Lindor, K. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80004-5 · Cited by 193
Joshi, S., Cauch-Dudek, K., Wanless, I. R., Lindor, K. D., Jorgensen, R., Batts, K., & Heathcote, J. E. (2002) · Hepatology · doi:10.1053/jhep.2002.30902 · Cited by 174
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis
Poupon, R., Chazouilleres, O., Corpechot, C., & Chrétien, Y. (2006) · Hepatology · doi:10.1002/hep.21229 · Cited by 170
Talwalkar, J. A., Keach, J. C., Angulo, P., & Lindor, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05703.x · Cited by 127
SUZUKI, Y., ARASE, Y., IKEDA, K., SAITOH, S., TSUBOTA, A., SUZUKI, F., KOBAYASHI, M., AKUTA, N., SOMEYA, T., MIYAKAWA, Y., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03372.x · Cited by 40
Research works printed but not linked: 18
- 10.1016/S1089-3261(02)00019-3 · DOI
- 10.1053/jhep.2001.23316 · DOI
- 10.1016/S0140-6736(97)05419-6 · DOI · Paper page
- 10.1002/hep.510280210 · DOI · Paper page
- 10.1097/00000478-199512000-00007 · DOI · Paper page
- 10.1056/NEJM199510123331502 · DOI · Paper page
- 10.1002/hep.1840180435 · DOI · Paper page
- 10.1080/0891693021000064272 · DOI · Paper page
- 10.1097/00042737-200406000-00012 · DOI · Paper page
- 10.1111/j.1572-0241.1998.224_a.x · doi:10.1111/j.1572-0241.1998.224_a.x · Paper page
- 10.1016/S0168-8278(96)80266-2 · DOI · Paper page
- 10.1002/hep.1840360615 · DOI · Paper page
- 10.1016/j.jhep.2005.10.017 · DOI · Paper page
- 10.1097/00029330-200602010-00013 · DOI · Paper page
- 10.1016/j.jhep.2004.01.009 · DOI · Paper page
- 10.1002/hep.20235 · DOI · Paper page
- 10.1002/hep.1840080414 · DOI · Paper page
- 10.1016/S0140-6736(85)91329-7 · DOI
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“Prognosis of PSC–AIH overlap syndrome was reported to be better than that of PSC [151], but worse than that of AIH [148].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
“Another study reported a similar proportion of patients with AIH-PSC ‘‘variant syndrome’’ (mainly young adults) and AIH achieving AIH biochemical response within one-year of therapy (although the exact combination of azathioprine, prednisone and UDCA varied between individual patients), but the long-term prognosis of…”
ResultDiagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Metadata
- Authors
- AL‐CHALABI, T., PORTMANN, B. C., BERNAL, W., MCFARLANE, I. G., & HENEGHAN, M. A.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2008-06-28
- Volume
- 28
- Issue
- 2
- Pages
- 209-220
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2070335189
- Cited by
- 149
- References
- 9
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long‐term outcome and survival. https://app.cochat.ai/papers/10.1111/j.1365-2036.2008.03722.x
- The paper
- AL‐CHALABI, T., PORTMANN, B. C., BERNAL, W., MCFARLANE, I. G., & HENEGHAN, M. A. (2008). Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long‐term outcome and survival. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2008.03722.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.